CompareMarketResearchRequest a sample
Home / Healthcare / Bioreactor

Healthcare · Market report

Bioreactor Market Size, Share and Forecast 2026-2036

The global bioreactor market is worth USD 13.7 bn in 2026 and is forecast to reach USD 35.5 bn by 2036, growing at a 10.0% CAGR. United States is the largest country market and Single-use bioreactors is the largest by type segment.

USD 13.7 bnMarket size 2026
USD 35.5 bnForecast 2036
10.0%CAGR 2026-2036
United StatesLargest country

Request a free sample Jump to the forecast

Report price: Starts from USD 1,999

5 segmentation views25 countries2026 to 2036 yearly forecast

Market overview

The global bioreactor market is worth USD 13.7 bn in 2026 and is forecast to reach USD 35.5 bn by 2036, growing at a 10.0% CAGR. United States is the largest country market and Single-use bioreactors is the largest by type segment.

ScopeBioreactors and fermenters for cell culture and microbial processes, including stainless-steel, glass and single-use vessels from laboratory to commercial scale.
IndustryHealthcare
Value 2025USD 12.5 bn
Value 2026USD 13.7 bn
Value 2036USD 35.5 bn
CAGR 2026-203610.0%
Volume 20263,252 thousand units
Volume 20367,637 thousand units
Average price 2026USD 4,208 per unit
Report priceStarts from USD 1,999
PublishedNovember 2026

Request a free sample of this report

Bioreactor market size and forecast, 2026-2036

Exhibit 1The global bioreactor market is forecast to grow from USD 13.7 bn in 2026 to USD 35.5 bn by 2036, more than doublingGlobal market value in USD: 2025 base year, 2026 estimate and forecast to 2036. CAGR 2026 to 2036: 10.0%
Bioreactor market value, 2025 to 2036Market value by year. 2025: USD 12.5 bn; 2026: USD 13.7 bn; 2027: USD 15.1 bn; 2028: USD 16.6 bn; 2029: USD 18.2 bn; 2030: USD 20.0 bn; 2031: USD 22.0 bn; 2032: USD 24.2 bn; 2033: USD 26.7 bn; 2034: USD 29.3 bn; 2035: USD 32.3 bn; 2036: USD 35.5 bn. Compound annual growth rate 2026 to 2036: 10.0%.202513.7 bn202622.0 bn203135.5 bn203610.0% CAGR

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

YearMarket value
2026USD 13.7 bn
2027USD 15.1 bn
2028USD 16.6 bn
2029USD 18.2 bn
2030USD 20.0 bn
2031USD 22.0 bn
2032USD 24.2 bn
2033USD 26.7 bn
2034USD 29.3 bn
2035USD 32.3 bn
2036USD 35.5 bn

Bioreactor market segmentation

By type

Exhibit 2Single-use bioreactors is the largest segment by type, with 42.0% of 2026 revenueEstimated share of 2026 global revenue, by type
Bioreactor market share by type, 2026Share of 2026 revenue by type. Single-use bioreactors: 42.0%; Stainless-steel bioreactors: 34.0%; Glass and benchtop bioreactors: 24.0%.Single-use bioreactors42.0%Stainless-steel bioreactors34.0%Glass and benchtop bioreactors24.0%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Single-use bioreactors42.0%54.1%USD 5.7 bn12.8%
Stainless-steel bioreactors34.0%25.3%USD 4.7 bn6.8%
Glass and benchtop bioreactors24.0%20.6%USD 3.3 bn8.3%

By cell type

Exhibit 3Mammalian cell adds the most revenue by cell type, growing from USD 7.9 bn in 2026 to USD 21.3 bn by 2036Estimated revenue in USD by cell type, 2026 and 2036 forecast
Bioreactor market by cell type, 2026 and 2036Revenue by cell type in 2026 and 2036. Mammalian cell: USD 7.9 bn in 2026, USD 21.3 bn in 2036, change +168%; Microbial: USD 3.3 bn in 2026, USD 7.3 bn in 2036, change +123%; Insect and others: USD 2.5 bn in 2026, USD 6.9 bn in 2036, change +180%.20262036 forecastChangeMammalian cell+168%7.9 bn21.3 bnMicrobial+123%3.3 bn7.3 bnInsect and others+180%2.5 bn6.9 bn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Mammalian cell58.0%59.9%USD 7.9 bn10.4%
Microbial24.0%20.6%USD 3.3 bn8.4%
Insect and others18.0%19.4%USD 2.5 bn10.8%

By end user

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Biopharmaceutical companies60.0%60.1%USD 8.2 bn10.0%
Contract manufacturers20.0%24.0%USD 2.7 bn12.0%
Academic and research institutes20.0%15.9%USD 2.7 bn7.5%

By scale

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Benchtop and lab24.0%20.0%USD 3.3 bn8.0%
Pilot22.0%22.0%USD 3.0 bn10.0%
Commercial54.0%58.0%USD 7.4 bn10.8%

By material

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Stainless steel40.0%34.0%USD 5.5 bn8.2%
Single use52.0%58.0%USD 7.1 bn11.2%
Glass8.0%8.0%USD 1.1 bn10.0%

Top 25 countries for bioreactor by revenue

Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 86.0% of 2026 revenue and the 25 countries below together hold 96.6%.

Exhibit 4United States is the largest country market at USD 4.5 bn in 2026, and the three largest countries hold 54.0% of global revenueEstimated 2026 revenue in USD and share of the global market, ten largest countries
Bioreactor market, ten largest countries in 2026Ten largest countries by 2026 revenue. United States: USD 4.5 bn, 33.0%; China: USD 1.6 bn, 12.0%; Germany: USD 1.2 bn, 9.0%; Switzerland: USD 821 mn, 6.0%; Japan: USD 684 mn, 5.0%; South Korea: USD 684 mn, 5.0%; United Kingdom: USD 684 mn, 5.0%; India: USD 548 mn, 4.0%; France: USD 548 mn, 4.0%; Singapore: USD 411 mn, 3.0%.United States4.5 bn 33.0%China1.6 bn 12.0%Germany1.2 bn 9.0%Switzerland821 mn 6.0%Japan684 mn 5.0%South Korea684 mn 5.0%United Kingdom684 mn 5.0%India548 mn 4.0%France548 mn 4.0%Singapore411 mn 3.0%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

#CountryValue 2026Share 2026Value 2036CAGR 2026-36
1United StatesUSD 4.5 bn33.0%USD 11.1 bn9.4%
2ChinaUSD 1.6 bn12.0%USD 5.5 bn12.9%
3GermanyUSD 1.2 bn9.0%USD 2.8 bn8.4%
4SwitzerlandUSD 821 mn6.0%USD 1.9 bn8.8%
5JapanUSD 684 mn5.0%USD 1.5 bn7.8%
6South KoreaUSD 684 mn5.0%USD 2.0 bn11.4%
7United KingdomUSD 684 mn5.0%USD 1.6 bn8.8%
8IndiaUSD 548 mn4.0%USD 1.8 bn12.5%
9FranceUSD 548 mn4.0%USD 1.2 bn8.5%
10SingaporeUSD 411 mn3.0%USD 1.1 bn10.4%
11IrelandUSD 274 mn2.0%USD 703 mn9.9%
12NetherlandsUSD 242 mn1.8%USD 625 mn9.9%
13DenmarkUSD 183 mn1.3%USD 472 mn9.9%
14BelgiumUSD 138 mn1.0%USD 355 mn9.9%
15SwedenUSD 114 mn0.8%USD 291 mn9.9%
16AustriaUSD 93 mn0.7%USD 238 mn9.8%
17ItalyUSD 90 mn0.7%USD 231 mn9.8%
18SpainUSD 79 mn0.6%USD 206 mn10.0%
19BrazilUSD 56 mn0.4%USD 163 mn11.3%
20TaiwanUSD 49 mn0.4%USD 142 mn11.2%
21IsraelUSD 37 mn0.3%USD 96 mn10.0%
22CanadaUSD 33 mn0.2%USD 85 mn10.0%
23AustraliaUSD 25 mn0.2%USD 64 mn10.0%
24PolandUSD 22 mn0.2%USD 64 mn11.3%
25MexicoUSD 19 mn0.1%USD 57 mn11.5%
Rest of worldUSD 461 mn3.4%USD 1.2 bn9.8%
Exhibit 5United States and China account for 48% of the USD 21.8 bn the market is forecast to add by 2036Forecast revenue added between 2026 and 2036 by country, in USD
Bioreactor market, where the growth to 2036 comes fromRevenue added between 2026 and 2036. Market value 2026: USD 13.7 bn. United States: +USD 6.6 bn; China: +USD 3.9 bn; Germany: +USD 1.5 bn; South Korea: +USD 1.3 bn; India: +USD 1.2 bn; 20 other countries: +USD 6.5 bn; Rest of world: +USD 717 mn. Market value 2036: USD 35.5 bn.Market value 202613.7 bnUnited States+6.6 bnChina+3.9 bnGermany+1.5 bnSouth Korea+1.3 bnIndia+1.2 bn20 other countries+6.5 bnRest of world+717 mnMarket value 203635.5 bn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

Competitive landscape

Group 1: Global leaders

  • Sartorius
  • Thermo Fisher Scientific
  • Cytiva
  • Merck KGaA
  • Eppendorf
  • Getinge

Group 2: Regional and specialist players

  • Pierre Guerin
  • Applikon
  • Solaris Biotechnology
  • Bioengineering AG
  • PBS Biotech
  • ABEC
  • Zeta Group
  • Kuhner
  • Corning

Group 3: Emerging and niche players

  • Distek
  • Infors HT
  • Cellexus
  • Celltainer Biotech

Research methodology

Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the bioreactor market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.

The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 10.0% is calculated from the resulting values.

The market is divided by type, by cell type, by end user, by scale, by material. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.

Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.

Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.

Read the full research methodology

Frequently asked questions

How big is the bioreactor market?

The global bioreactor market is estimated at USD 12.5 bn in 2025 and USD 13.7 bn in 2026.

How fast will the bioreactor market grow?

It is forecast to reach USD 35.5 bn by 2036, a compound annual growth rate of 10.0% from 2026, an increase of USD 21.8 bn.

Which country is the largest market for bioreactor?

United States is the largest market by revenue at USD 4.5 bn in 2026, 33.0% of the global total. The three largest countries together hold 54.0%.

Which country is growing fastest?

Among the ten largest markets, China is growing fastest at 12.9% a year from 2026 to 2036.

Which bioreactor segment is largest?

In the by type split, Single-use bioreactors is the largest segment with 42.0% of 2026 revenue.

Who are the leading bioreactor companies?

Global leaders include Sartorius, Thermo Fisher Scientific, Cytiva, Merck KGaA.

Need the full report?

Request a sample to see the structure, tables and country detail.

Request a free sample

Related markets in Healthcare

← Biopharmaceutical Logistics Biosafety Cabinet →

All Healthcare markets →

Request a sample